The following is a summary of “Aspirin 162 mg vs 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a comparative effectiveness open-label randomized trial (ASPREO),” published in the March 2025 issue of American Journal of Obstetrics & Gynecology by Amro et al. Inconsistent aspirin dosing recommendations for preeclampsia prevention and potential resistance in individuals […]
The post Comparing Aspirin Doses for Preeclampsia in High-Risk Pregnancy first appeared on Physician’s Weekly.
